FREE Daily Stock Alerts From Stock-PR.com
American Video Teleconferencing Corp. (OTC:AVOT)
American Video Teleconferencing Corp. is pleased to announce that it has hired a French speaking geologist to search the archives of the Quebec Department of Mines for Rare Earths showings not on a current computer file. AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. As neither the Federal nor Quebec Governments have carried out any air borne surveys in this area, AVOT will seek a contractor to do an air borne Mag-EM radiometric survey. This survey will cover its present holdings and the immediate surrounding area looking for future acquisitions. We are pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration. The Quebec Government gives a rebate up to 45% for property expenditures.
China has been one of the main supplier to the US of the Earth's rare mineral supplies, with these rare minerals American manufacturers are able to make high-tech products such as cell phones, wind turbines, and guided missiles, but all that might come to a screeching halt now that China has stopped supplying the material, the New York Times has reported.
In the wake of China's decision America now must look for other sources, that will be more reliable for our future needs, and AVOT may just be the new source, here's why.
AVOT believes the rare earths industry is where it wants to maintain a very strong focus and is looking to expand its holdings. AVOT is currently looking for these Rare Earths Minerals in Canada, the US's Northern neighbor.
AVOT is seeking a contractor to do an air borne Mag-EM radiometric survey for its present holdings and the immediate surrounding area looking for future acquisitions. AVOT is pleased to be working in the Province of Quebec as it is rated the number one jurisdiction in the world to carry out mineral exploration. The Quebec Government gives a rebate up to 45% for property expenditures.
Presently AVOT is in the final stage of negotiations with Kondor Gold Pyt. in Australia.
Experts warn that the U.S. relies on China for almost its entire amount of rare earths, and has let its own rare earth production languish despite possessing about 15 percent of the world’s reserves. A draft of a Chinese rare earths plan for 2009-2015 expresses that China’s own industrial growing demand could soon cause restrictions or bans on the export of rare earths.
During a recent industry summit, some authorities argued that China’s rare earth industry will need to eliminate the price war, promote technological innovation and target the sustainable growth and development of the industry.
Enzo Biochem (NYSE:ENZ) is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, Enzo Biochem has concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of Enzo Biochem’s technologies are applicable to the biomedical and pharmaceutical research markets, and the Company is further using these technologies as a platform for entry into the clinical diagnostics market. Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, Enzo’s work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. In the course of Enzo Biochem’s extensive research and development activities, they have built a significant patent position consisting of numerous pioneer patents and applications that encompass core technologies.
Enzo Biochem, Inc. reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.
“We are pleased to report that our program instituted this quarter aimed at making Enzo more efficient and designed to produce more effective use of our assets is beginning to show results, as demonstrated by improved performance, ” said Barry Weiner, President. “While we are in the early stages of this comprehensive program, the results experienced to date are very encouraging.”
“Moreover, in the first quarter, we achieved several milestones. We submitted Colon Sentry, a unique assay for risk-stratification of colon cancer occurrence, to the New York State Department of Health for approval. In addition, we began enrolling the first patients in our clinical trial of Optiquel™, our candidate therapeutic for the treatment of autoimmune uveitis. We also continued to roll out proprietary products and systems designed to aid in drug development,” he added.
Enzo Clinical Labs (”Lab”) benefited in the quarter from increased market share and service volume increases in connection with its being named a participating provider for Empire BlueCross BlueShield in the metropolitan New York area.
Enzo Life Sciences’ profitability for the quarter improved due to benefits from the plan instituted in July to integrate functions and rationalize workforce levels.
Provident Energy Trust (NYSE:PVX) announced on Jan 3, 2011 the closing of the Plan of Arrangement on January 1, 2011 pursuant to which Provident Energy Trust ("the Trust") converted into the dividend-paying corporation "Provident Energy Ltd." It is anticipated that Provident's common shares will commence trading on the Toronto Stock Exchange ("TSX") on or about January 7, 2011 and on the New York Stock Exchange ("NYSE") on January 3, 2011 under the symbols PVE and PVX, respectively. Provident's convertible debentures will continue trading on the TSX under the symbols PVE.DB.C, PVE.DB.D and PVE.DB.E. The trust units of the Trust will be delisted from both the TSX and the NYSE.
Provident Energy Trust operates as an open-ended energy income trust that owns and manages a natural gas liquids midstream services and marketing business. The company involves in the processing, extraction, transportation, loading, storage, and marketing of natural gas liquids in central Canada and the eastern United States.
Lexington Realty Trust (NYSE:LXP) announced that it declared cash dividends of $0.503125 per Series B Cumulative Redeemable Preferred Share, $0.8125 per Series C Cumulative Convertible Preferred Share and $0.471875 per Series D Cumulative Redeemable Preferred Share. The Series B and Series C Preferred Share dividends are payable on or about February 15, 2011, to shareholders of record of the Series B and Series C Preferred Shares as of January 31, 2011. The Series D Preferred Share dividend is payable on or about January 14, 2011, to shareholders of record of the Series D Preferred Shares as of December 31, 2010.
Lexington Corporate Properties Trust operates as a self-managed and self-administered real estate investment trust (REIT). The company acquires, owns, and manages a portfolio of office, industrial, and retail properties net-leased to corporate tenants in the United States.
China Green Agriculture, Inc. (NYSE:CGA) announced the successful completion of Jinong's 11th annual distributor conference held from December 8 to 11, 2010 at China Green Agriculture's headquarters in Xi'an, Shaanxi Province. Over 250 distributors and guests of Jinong from all over the nation toured the Company's headquarters and both the production and R&D facilities during the four-day event. During the main ceremony in Xi'an, the management team shared with attendees the Company's sales strategy and marketing plans for 2011, and recognized 12 distributors for their outstanding performance in 2010.
China Green Agriculture, Inc., through its subsidiaries, engages in the research, development, manufacture, and distribution of humic acid based compound fertilizers in China. Humic acid is a natural, organic ingredient for a balanced, fertile soil, and the primary constituents of organic matter.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received from the company 2,000,000 shares of (144) restricted common stock of American Video Teleconferencing Corp. (OTC:AVOT) for 12 months IR Services and 1,000,000 shares of (144) restricted common stock for its IT services.
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.